Non-Hodgkin's Lymphoma
News
Worse Prognosis for “Bulky” Disease Diffuse Large B-Cell Lymphoma
(05/08/2008)
Young patients with diffuse large-B-cell lymphoma (DLBCL) with cancerous masses that are 10.0 centimeters or greater in diameter are considered to have “bulky” disease and have a worse prognosis than those with smaller masses. These findings were published in Lancet Oncology.
Treanda® Included in NCCN Guidelines for CLL and NHL
(05/05/2008)
The chemotherapy agent Treanda® (bendamustine) has been added to the treatment guidelines of the National Comprehensive Cancer Network (NCCN) as an accepted treatment option for chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL).
Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas
(04/07/2008)
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in lymphomas difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.
Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma
(04/01/2008)
Statins may reduce the effectiveness of Rituxan® (rituximab) in treatment of non-Hodgkin’s lymphoma (NHL), according to a recently published article in PLoS Med (the Public Library of Science journal).
Stem Cell Transplant May Improve Survival Among Elderly with Relapsed Non-Hodgkin’s Lymphoma
(03/11/2008)
A recent study reveals that elderly patients with relapsed non-Hodgkin’s Lymphoma (NHL) may benefit from autologous stem cell transplant. Results from the study, conducted at the M.D. Anderson Cancer Center in Texas, were recently published in Annals of Oncology.
More
Non-Hodgkin's Lymphoma
Cancer News...